Disturbances of growth of cells, classification of tumors, general biology of tumors, spread of malignant tumors, etiology and pathogenesis of cancer

Curriculum Unit: 4. Cancer:

This study module covers "Disturbances of growth of cells, classification of tumors, general biology of tumors, spread of malignant tumors, etiology and pathogenesis of cancer", an integral component of the Year 2 Doctor of Pharmacy (Pharm.D) curriculum under Pathophysiology (Cancer). Designed for clinical pharmacy scholars, the syllabus emphasizes mechanistic understanding, clinical relevance, and high-yield examination competencies.

Upon reviewing this syllabus topic, Pharm.D students are expected to demonstrate proficiency in:

• Understand the foundational etiology, classification, and clinical significance of Disturbances of growth of cells, classification of tumors, general biology of tumors, spread of malignant tumors, etiology and pathogenesis of cancer.
• Analyze the underlying pathophysiology and disease manifestations relevant to Cancer.
• Evaluate evidence-based pharmacotherapeutic management, therapeutic drug choices, and dosage individualization.
• Identify critical patient monitoring parameters, adverse drug reactions (ADRs), and drug-drug interactions.

Standard literature and institutional sources for Pathophysiology:

• [1]Pharmacy Council of India (PCI) Pharm.D Curriculum Syllabus Guidelines
• [2]Robbins & Cotran Pathologic Basis of Disease (Kumar, Abbas, Aster)
• [3]Pathophysiology of Disease: An Introduction to Clinical Medicine (Hammer & McPhee)